![]() Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. | Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer. | ||
Founding Date | Founding Date 2020 | Founding Date 1987 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Palo Alto, US HQ | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | |
Employees | Employees 4521% decrease | Employees 18,0006% increase | Employees 575 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 110.5 b | Valuation ($) 2.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $13m (FY, 2025) | Revenue (est.) $29.4b (FY, 2025) | Revenue (est.) $102.8m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods $6.2b (FY, 2025) | Cost of goods $76.1m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit $23.2b (FY, 2025) | Gross profit $26.7m (FY, 2022) |
Net income | Net income ($68.9m) (FY, 2025) | Net income $8.5b (FY, 2025) | Net income ($104.4m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 57.5m | Total funding raised N/A | Total funding raised $ 252.1m |

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View companyAthenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer.
View company